These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 31763067)
1. Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme. Xia X; Cao F; Yuan X; Zhang Q; Chen W; Yu Y; Xiao H; Han C; Yao S PeerJ; 2019; 7():e7974. PubMed ID: 31763067 [TBL] [Abstract][Full Text] [Related]
2. CXCR4 expression varies significantly among different subtypes of glioblastoma multiforme (GBM) and its low expression or hypermethylation might predict favorable overall survival. Ma X; Shang F; Zhu W; Lin Q Expert Rev Neurother; 2017 Sep; 17(9):941-946. PubMed ID: 28685624 [TBL] [Abstract][Full Text] [Related]
3. SOCS3 promoter hypermethylation is a favorable prognosticator and a novel indicator for G-CIMP-positive GBM patients. Feng Y; Wang Z; Bao Z; Yan W; You G; Wang Y; Hu H; Zhang W; Zhang Q; Jiang T PLoS One; 2014; 9(3):e91829. PubMed ID: 24633048 [TBL] [Abstract][Full Text] [Related]
4. Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma. Ding Y; Liu H; Zhang C; Bao Z; Yu S Aging (Albany NY); 2022 Mar; 14(5):2320-2334. PubMed ID: 35256538 [TBL] [Abstract][Full Text] [Related]
5. Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling. Alafate W; Xu D; Wu W; Xiang J; Ma X; Xie W; Bai X; Wang M; Wang J J Exp Clin Cancer Res; 2020 Nov; 39(1):239. PubMed ID: 33176854 [TBL] [Abstract][Full Text] [Related]
7. DYRK1A-mediated PLK2 phosphorylation regulates the proliferation and invasion of glioblastoma cells. Tan S; Zhao J; Wang P Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37387444 [TBL] [Abstract][Full Text] [Related]
8. High EMP3 expression might independently predict poor overall survival in glioblastoma and its expression is related to DNA methylation. Yue H; Xu Q; Xie S Medicine (Baltimore); 2018 Jan; 97(1):e9538. PubMed ID: 29505529 [TBL] [Abstract][Full Text] [Related]
9. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme. Zhao H; Zhou X; Yuan G; Hou Z; Sun H; Zhai N; Huang B; Li X Clin Transl Oncol; 2021 Mar; 23(3):565-571. PubMed ID: 32661826 [TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma. Jia D; Lin W; Tang H; Cheng Y; Xu K; He Y; Geng W; Dai Q Aging (Albany NY); 2019 Aug; 11(15):5579-5592. PubMed ID: 31395792 [TBL] [Abstract][Full Text] [Related]
11. Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions. Benetatos L; Dasoula A; Hatzimichael E; Syed N; Voukelatou M; Dranitsaris G; Bourantas KL; Crook T Ann Hematol; 2011 Sep; 90(9):1037-45. PubMed ID: 21340720 [TBL] [Abstract][Full Text] [Related]
12. Construction of Novel DNA Methylation-Based Prognostic Model to Predict Survival in Glioblastoma. Zhao J; Wang L; Kong D; Hu G; Wei B J Comput Biol; 2020 May; 27(5):718-728. PubMed ID: 31460783 [TBL] [Abstract][Full Text] [Related]
13. RPP25 as a Prognostic-Related Biomarker That Correlates With Tumor Metabolism in Glioblastoma. Xiao D; Wu J; Zhao H; Jiang X; Nie C Front Oncol; 2021; 11():714904. PubMed ID: 35096558 [TBL] [Abstract][Full Text] [Related]
14. Identification of glioblastoma-specific prognostic biomarkers via an integrative analysis of DNA methylation and gene expression. Mao YK; Liu ZB; Cai L Oncol Lett; 2020 Aug; 20(2):1619-1628. PubMed ID: 32724403 [TBL] [Abstract][Full Text] [Related]
15. Identification of aberrantly methylated differentially expressed genes in glioblastoma multiforme and their association with patient survival. Zhang M; Lv X; Jiang Y; Li G; Qiao Q Exp Ther Med; 2019 Sep; 18(3):2140-2152. PubMed ID: 31452706 [TBL] [Abstract][Full Text] [Related]
16. Construction and Validation of an Immune-Related Risk Score Model for Survival Prediction in Glioblastoma. Ren W; Jin W; Liang Z Front Neurol; 2022; 13():832944. PubMed ID: 35370869 [TBL] [Abstract][Full Text] [Related]
17. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma. Shwetha SD; Shastry AH; Arivazhagan A; Santosh V Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112 [TBL] [Abstract][Full Text] [Related]
18. Genome-wide methylation profiling identifies an essential role of reactive oxygen species in pediatric glioblastoma multiforme and validates a methylome specific for H3 histone family 3A with absence of G-CIMP/isocitrate dehydrogenase 1 mutation. Jha P; Pia Patric IR; Shukla S; Pathak P; Pal J; Sharma V; Thinagararanjan S; Santosh V; Suri V; Sharma MC; Arivazhagan A; Suri A; Gupta D; Somasundaram K; Sarkar C Neuro Oncol; 2014 Dec; 16(12):1607-17. PubMed ID: 24997139 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of carboxypeptidase Q and its methylation in glioblastoma. Liu Q; Wang R; Li Z; Peng Y; Qin W; Peng XM; Liu ZG Transl Cancer Res; 2023 May; 12(5):1073-1087. PubMed ID: 37304538 [TBL] [Abstract][Full Text] [Related]
20. Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme. Huang R; Li Z; Li C; Wang G; Yan P; Peng L; Wang J; Zhu X; Hu P; Zhang J; Chang Z; Huang Z; Cheng L; Zhang J Front Genet; 2019; 10():1380. PubMed ID: 32117422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]